A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer - Concepedia

Concepedia

Publication | Open Access

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

DOI Full Paper Access

35

Citations

31

References

2022

Year

Hirotaka Hasegawa, Kohei Shitara, Shuji Takiguchi, Noriaki Takiguchi, Seiji Ito, Mitsugu Kochi, Hidehito Horinouchi, Takahiro Kinoshita, Takaki Yoshikawa, Kei Muro,

Abstract

Neoadjuvant nivolumab monotherapy is feasible with an acceptable safety profile and induces a MPR in certain patients with resectable GC. (Registration: clinicaltrials.jp, JapicCTI-183895).

References

	Year	Citations

Page 1